Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

2009559 citationsJournal Articlebronze Open Access

Authors

Hyman B. Muss · University of Vermont

Donald A. Berry · The University of Texas MD Anderson Cancer Center

Constance Cirrincione · Duke Medical Center

Maria Theodoulou · Memorial Sloan Kettering Cancer Center

Ann M. Mauer

Alice B. Kornblith · Dana-Farber Cancer Institute

Ann H. Partridge · Dana-Farber Cancer Institute

Abstract

Standard adjuvant chemotherapy is superior to capecitabine in patients with early-stage breast cancer who are 65 years of age or older. (ClinicalTrials.gov number, NCT00024102.)

Topics & Keywords

Breast Cancer Treatment Studies Cancer Treatment and Pharmacology HER2/EGFR in Cancer Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 360, Issue 20, pp. 2055-2065

DOI: 10.1056/nejmoa0810266

Field-Weighted Citation Impact: 19.73